Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...
The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
2don MSN
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
2don MSN
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...
Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...
Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results